# Regional Anaesthesia and Substance P in Head and Neck Cancer

> **NCT03081897** · NA · SUSPENDED · sponsor: **Charite University, Berlin, Germany** · enrollment: 40 (estimated)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** SPRANC Block group
- **DRUG:** SPRANC Control group

## Key facts

- **NCT ID:** NCT03081897
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2016-07
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** for organizational reasons
- **Last updated:** 2022-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081897, "Regional Anaesthesia and Substance P in Head and Neck Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03081897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*